Similarly, low editing of miR-589 in glioma was reported to change its specificity from disintegrin and metalloproteinase domain-containing protein 12 (ADAM12), a primary target of miR-589, towards protocadherin 9 (PCDH9), thereby promoting cell migration and invasion [135]. Here, PCDH9 is linked to central nervous system cancer.